DrugPatentWatch Database Preview
Zydus Pharms Usa Company Profile
What is the competitive landscape for ZYDUS PHARMS USA, and when can generic versions of ZYDUS PHARMS USA drugs launch?
ZYDUS PHARMS USA has one hundred and ninety-eight approved drugs.
There is one US patent protecting ZYDUS PHARMS USA drugs. There are nine tentative approvals on ZYDUS PHARMS USA drugs.
There are two patent family members on ZYDUS PHARMS USA drugs in two countries and two hundred and ninety supplementary protection certificates in fourteen countries.
Summary for Zydus Pharms Usa
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 166 |
| Ingredients: | 165 |
| NDAs: | 198 |
Drugs and US Patents for Zydus Pharms Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 207762-010 | Jan 11, 2019 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Zydus Pharms Usa Inc | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 201686-001 | Oct 10, 2012 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Zydus Pharms Usa Inc | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 078243-001 | Oct 6, 2010 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Zydus Pharms Usa Inc | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 078888-002 | Feb 7, 2014 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Zydus Pharms Usa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011089623 | ➤ Try a Free Trial |
| Japan | 2013516459 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Zydus Pharms Usa Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0300652 | C300117 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: DEXMEDETOMIDINE, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH IN FARMACEUTISCH OPZICHT AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZ ONDER DEXMEDETOMIDINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/2/02/033/001 20020830 |
| 1519731 | 92269 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
| 1412357 | PA2008013 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REG. NO/DATE: EU/1/08/455/001-014 20080716 |
| 1003503 | 30/2006 | Austria | ➤ Try a Free Trial | PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SAEUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN; NAT. REGISTRATION NO/DATE: 1-26271, 1-26273 20060330; FIRST REGISTRATION: FR 369300.9;369301.5; 369302.1;369303.8;369304.4;369305.0; 20050707 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
